Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-3142-2026

Philips North America recalls Philips PIC iX Essentials REF:867093

Philips North AmericaCambridge, MA, United StatesReported Sep 23, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

Due to software malfunction, patient information system may freeze and become unresponsive.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Philips PIC iX Essentials1 code
  • 867093

Lot / code information

All PIC iX software versions 4.0-4.5/UDI: (01)00884838122772

What the firm is doing

On July 31, 2026, Philips North America LLC issued an urgent medical device correction to affected consignees via USPS certified mail. Philips requested consignees to take the following actions: Users: 1. In cases where central monitoring has halted, please ensure that triaging of patients at bedside and a change in workflow occurs to more closely monitor patient status. Ensure audible alarm volume is on high in-patient rooms in case bedside devices disconnect and do not provide visual indicators that communication with the central. 2. Pass this notice to those who need to be aware within your organization or to any organization where affected product(s) have been potentially transferred. 3. Place this Urgent notification with the documentation of the Philips Patient Information Center (PIC) iX and associate devices in a place where it is most likely to be seen and viewed. 4. Implement the Technical Solution established by Philips as soon as available within the defined timeframe. Distributors: 1. Send the attached URGENT Medical Device Correction to each customer to whom you have distributed any affected product(s) 2. Perform a good faith effort to reach each customer a minimum of three (3) times, and if possible, using multiple contact methods. 3. Implement the Technical Solution established by Philips as soon as available within the timeframe communicated by Philips, and confirm with Philips the implementation of the correction of all affected product(s). In case any product(s) cannot be corrected, inform Philips of the reason why the Technical Solution could not be implemented.

DistributionShow details

Worldwide - US Nationwide distribution including in the states and territories of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, PR and the countries of Andorra, Utd. Arab. Emir., Argentina, Austria, Australia, Aruba, Bosnia-Herz., Bangladesh, Belgium, Bulgaria, Bahrain, Bolivia, Brazil, Canada, Switzerland, Chile, Colombia, Costa Rica, Cyprus, Czech Republic, Germany, Denmark, Dominican Rep, Algeria, Estonia, Spain, Finland, Fiji, Faroe Islands, France, United Kingdom, Gibraltar, Guadeloupe, Greece, Hong Kong, Croatia, Hungary, Indonesia, Ireland, Israel, India, Iraq, Iceland, Italy, Jordan, Japan, Kenya, South Korea, Kuwait, Lebanon , Sri Lanka, Lithuania, Luxembourg, Latvia, Libya, Morocco, Monaco, Montenegro, Macedonia, Macao, Martinique, Maldives, Mexico, Malaysia, Namibia, Nicaragua, Netherlands, Norway, New Zealand, Oman, Panama, Peru, Philippines, Pakistan, Poland, Puerto Rico, Portugal, Qatar R¿union, Romania, Serbia, Russian Fed., Saudi Arabia, Sweden, Singapore, Slovenia, Slovakia, Thailand, Turkmenistan, Tunisia, T¿rkiye, Taiwan, Ukraine, Uzbekistan, Vietnam, South Africa.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls